With patented technology, TSE (Tumour Specific Electroporation™), offers safe, effective and flexible treatment capabilities for non-repsonsive and cosmetically difficulty tumours.
Coupled with low-dose chemotherapy delivered intravenously or by local site injection, TSE has been designed to achieve positive clinical outcomes on a level previously not possible. Animal and clinical models available for hire and purchase.
